Baxter International (BAX) Curent Deferred Tax Liability (2009 - 2014)
Baxter International (BAX) reported Curent Deferred Tax Liability of $9.0 million for Q4 2014, down 57.14% year-over-year from $21.0 million in Q4 2013, and down 57.14% quarter-over-quarter from $21.0 million in Q4 2013.
Baxter International (BAX) Curent Deferred Tax Liability (2009 - 2014) Analysis & Trends
Baxter International (BAX) has 6 years of Curent Deferred Tax Liability data on file, last reported at $9.0 million in Q4 2014.
- Curent Deferred Tax Liability for Q4 2014 came in at $9.0 million, down 57.14% year-over-year; the trailing twelve-month figure through Dec 2014 was $9.0 million (down 57.14% YoY), and the FY2014 annual result was $9.0 million, down 57.14% from the prior year.
- Curent Deferred Tax Liability fell to $9.0 million in Q4 2014 per BAX's latest filing, from $21.0 million in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $878.0 million in Q4 2012 and troughed at $9.0 million in Q4 2014.
- A 5-year average of $456.2 million and a median of $635.0 million in 2010 frame the typical range for Curent Deferred Tax Liability.
- The sharpest annual moves came in 2010 and 2013: Curent Deferred Tax Liability surged 31.74% in 2010, then slumped 97.61% in 2013.
- A 5-year view of Curent Deferred Tax Liability shows it stood at $635.0 million in 2010, then advanced by 16.22% to $738.0 million in 2011, then gained by 18.97% to $878.0 million in 2012, then tumbled by 97.61% to $21.0 million in 2013, then plunged by 57.14% to $9.0 million in 2014.
- Business Quant data shows BAX's Curent Deferred Tax Liability at $9.0 million in Q4 2014, $21.0 million in Q4 2013, and $878.0 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 9.00 Mn |
| Dec 31, 2014 | 9.00 Mn |
| Dec 31, 2013 | 21.00 Mn |
| Dec 31, 2013 | 21.00 Mn |
| Dec 31, 2012 | 878.00 Mn |
| Dec 31, 2012 | 878.00 Mn |
| Dec 31, 2011 | 738.00 Mn |
| Dec 31, 2011 | 738.00 Mn |
| Dec 31, 2010 | 635.00 Mn |
| Dec 31, 2010 | 635.00 Mn |
| Dec 31, 2009 | 482.00 Mn |
| Dec 31, 2009 | 482.00 Mn |